Thyroid Cancer, Nonmedullary, 2 (NMTC2)

非髓样甲状腺癌2型(来自ICD-11)

别称:

Thyroid Carcinoma, Follicular

Follicular Thyroid Carcinoma

Nmtc2

Moderately Differentiated Follicular Carcinoma of Thyroid Gland

Well Differentiated Follicular Carcinoma of Unspecified Site

Well Differentiated Follicular Carcinoma of Thyroid Gland

Pure Follicle Follicular Carcinoma of Unspecified Site

Trabecular Follicular Carcinoma of Unspecified Site

Trabecular Follicular Carcinoma of Thyroid Gland

Pure Follicular Carcinoma of Thyroid Gland

Follicular Carcinoma of Unspecified Site

Pure Follicle Carcinoma of Thyroid Gland

Thyroid Carcinoma, Follicular, Somatic

Cancer, Thyroid, Nonmedullary, Type 2

Thyroid Cancer, Non-Medullary, 2

Thyroid Follicular Carcinoma

Thyroid Gland Adenocarcinoma

Thyroid Cancer, Follicular

Follicular Thyroid Cancer

加入收藏

基础信息

疾病表征

基因 & 突变

靶点药物

疾病模型

文献报道

甲状腺癌，非髓样，2型，也称为甲状腺癌，滤泡性，与分化型甲状腺癌和先天性，非胶质性，1型甲状腺功能减退症有关。与甲状腺癌，非髓样，2型相关的重要基因是SRGAP1（SLIT-ROBO Rho GTPase激活蛋白1），其相关通路/超通路包括信号转导和磷脂酶C通路。在该疾病的背景下提到了药物舒尼替尼和罗米地辛。附属组织包括甲状腺和肺，相关表型为滤泡性甲状腺癌和乳头状甲状腺癌。

查看原文参与反馈